Abstract
Oral carcinoma is the sixth most common cancer globally, with one death occurring every hour. Focal adhesion kinase (FAK) is an intercellular protein tyrosine kinase, a key indicator of the development of oral cancer. FAK overexpression leads to the initiation and significant progression of metastasis in head and neck cancers, indicating its vital role in cancer progression and potential as a biomarker for early oral malignant transformation. The present review elaborates on FAK's function in oral malignancies since it could serve as a biomarker of the initial stages of oral malignant transformation and a possible predictive factor for risk assessment.
| Original language | English |
|---|---|
| Article number | 103852 |
| Journal | Drug Discovery Today |
| Volume | 29 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- biomarker
- cancer therapeutics
- focal adhesion kinase
- oral cancer
Fingerprint
Dive into the research topics of 'Molecular and functional insight into focal adhesion kinases: Therapeutic implications for oral malignancies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver